GE HealthCare has entered into an agreement to acquire Intelligent Ultrasound's clinical artificial intelligence software business for $51 million. Intelligent Ultrasound specializes in integrated ...

GE HealthCare this past week said it will acquire the clinical artificial intelligence business of Intelligent Ultrasound Group. The price for the software buy is about $51 million, the companies said ...

Integrated artificial intelligence (AI) and advanced tools improve image quality and exam speed to help providers make accurate diagnoses and tailor precision care for women Latest Voluson Signature ...

Voluson Expert 22 represents a major step forward in ultrasound innovation from a market leader in Women’s Health Ultrasound Next-generation architecture behind Voluson Expert 22 includes Voluson ...

GE HealthCare has raised the curtain on two ultrasound systems equipped with artificial intelligence programs designed to assist in diagnosing conditions in women’s health, including obstetric exams.

GE Healthcare Technologies Inc. entered into a conditional agreement to acquire the clinical AI business of Intelligent Ultrasound Group plc for £40.5 million (US$51 million). The deal is part of GE ...

GE HealthCare has named new leaders of two key segments as it makes minor restructuring moves. The Chicago-based medical equipment manufacturer appointed Roland Rott president and CEO of the imaging ...

A little more than a year after acquiring the artificial intelligence developer Caption Health, GE HealthCare has brought its cardiac ultrasound coaching programs to its hand-held scanner. Caption’s ...

Building on its 125-year legacy of medical imaging innovation and a 16-year relationship with NVIDIA, the two companies team up to advance AI-driven autonomous solutions designed to ease the growing ...

GE Healthcare has announced the latest version of its Vivid E9 cardiovascular ultrasound system has received FDA 510(k) clearance, according to a news release. Features of the Vivid E9 Breakthrough ...

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for the updated portfolio of Voluson™ ...